Common Genetic Variants Linked to Acute Myeloid Leukemia Risk and Survival

Acute myeloid leukemia is defined by a complex landscape of somatic mutations that drive pathogenesis and dictate clinical outcomes [1]. Current diagnostic frameworks, such as the World Health Organization classification, increasingly rely on these molecular biomarkers to categorize disease and guide treatment selection [2, 3]. Despite these advances in understanding the somatic genome, the heritable component of leukemia risk outside of rare familial syndromes is not yet fully understood [4]. Clinicians currently utilize risk stratification models based on genetic aberrations to predict response to targeted therapies [5]. However, the interplay between a patient's germline background and the eventual development of specific cytogenetic subgroups remains a critical area of investigation. A new study now provides evidence linking common genetic variations to both overall risk and specific high-risk subtypes of the disease.